Search

Piotr J Kraj

from Norfolk, VA
Age ~63
Get Report
Also known as:
Piotr Y Kraj, Piotr Krai
Phone and address:
507 Brackenridge Ave, Norfolk, VA 23505
(706) 863-1073
Related to:
Pawel Kraj, 29Barbara Kraj, 58
Connected to:
Aida Kraja, 40Bujar Kraja, 53Ilirjana Kraja, 57Brian Krajack, 43Maryann Krajacic, 71Michael W Krajanowski, 42Alan R Krajbich, 37Peter J Krajc, 89Witold M Krajcer, 73Dimitar Krajcev, 70

Piotr Kraj Phones & Addresses

  • 507 Brackenridge Ave, Norfolk, VA 23505 (706) 863-1073
  • 3503 Saxton Rd, Martinez, GA 30907 (706) 863-1073 (706) 737-8227
  • 2515 Center West Pkwy W, Augusta, GA 30909 (706) 737-8227
  • 1605 Parnell St, Augusta, GA 30904 (706) 737-8227
  • 824 Hickman Rd, Augusta, GA 30904 (706) 737-8227
  • 824 Hickman Rd #18, Augusta, GA 30904 (706) 737-8227
  • Philadelphia, PA

Work

Company: Old dominion university Position: Associate professor

Industries

Research

Resumes

Resumes

Piotr Kraj Photo 1

Associate Professor

View page
Location:
Norfolk, VA
Industry:
Research
Work:
Old Dominion University
Associate Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Piotr Kraj
Principal
Piotr Kraj DVM PH.D
Veterinary Services
405 Hale St, Augusta, GA 30901
Piotr J. Kraj
Phd
Old Dominion University
College/University
5115 Hampton Blvd, Norfolk, VA 23529
(757) 683-3000

Publications

Us Patents

Method Of Enhancing T Cell Immunity By Selection Of Antigen Specific T Cells

View page
US Patent:
20030021796, Jan 30, 2003
Filed:
May 2, 2002
Appl. No.:
10/137745
Inventors:
Leszek Ignatowicz - Evans GA, US
Piotr Kraj - Augusta GA, US
International Classification:
A61K039/00
A61K039/12
A61K039/02
A61K039/002
US Classification:
424/185100, 424/186100, 424/190100, 424/191100
Abstract:
Disclosed is an in vivo system for the development of CD4 T cells bearing class II MHC restricted TCR. The cells are induced by the administration of a positively selecting, soluble peptide. Following peptide delivery, double-positive CD4CD8 cells expressing this TCR differentiate into CD4 cells in vivo, or in vitro in thymic organ cultures. This system facilitates the development of antigen-specific functional CD4 T cells in a controlled manner, after administration of the peptide. The positively selected CD4 T cells remain in the periphery for a prolonged time and respond to the appropriate antigenic challenge.
Control profile
Piotr J Kraj from Norfolk, VA, age ~63 Get Report